News | Artificial Intelligence | February 25, 2021

Expanded access to AI for oncology sponsors will empower actionable insights to optimize drug development and help improve patients' quality of life

AiCure, an AI and data analytics company focused on improving clinical trials, and OncoBay Clinical, a full-service boutique contract research organization (CRO) specializing in the simplification of complex oncology programs, today announced a strategic partnership to provide oncology sponsors with scalable, AI-powered insights to improve patient care and optimize drug development.

February 25, 2021 —  AiCure, an AI and data analytics company focused on improving clinical trials, and OncoBay Clinical, a full-service boutique contract research organization (CRO) specializing in the simplification of complex oncology programs, today announced a strategic partnership to provide oncology sponsors with scalable, AI-powered insights to improve patient care and optimize drug development. A subsidiary of the Moffitt Cancer Center, OncoBay will make AiCure's proprietary AI platform available for oncology trials, providing sponsors and sites with a more holistic understanding of patient health and site optimization.

"Cancer treatment – particularly during clinical trials – is a complex experience for patients both physically and emotionally. By partnering with OncoBay, we hope increased access to technology will help improve the quality of life for these patients and make their treatment journey as simple as possible," said Ed Ikeguchi, M.D., CEO of AiCure. "Through their own smartphones, patients are able to get much needed support without leaving their homes. Enhancing the quality of trial data collected in between clinic visits will also help sites with decision-making to create meaningful, data-driven trials."

The oncology drug pipeline has grown by 63% since 2013, but the average success rate of oncology drugs is only 3.4%. To address this discrepancy and the unique challenges of oncology trials, particularly given the complex treatment regimens, AiCure and OncoBay aim to improve patient support and trial retention, while also providing sponsors and sites with greater visibility into patient behavior. Through AiCure's patient engagement solution, Patient Connect, oncology sites can remotely monitor patients and use real-time communication tools to guide them through complex treatment protocols, including which medication to take and when, as well as allow direct access to a clinician. Verified patient compliance information makes pharmacokinetic data instantly more robust, and these actionable insights into trial and site performance empower sponsors to make proactive, data-driven decisions, ultimately accelerating trial timelines and lowering costs of high-quality drugs. 

"With oncology's data landscape growing in complexity, we need to arm our sponsors with the tools to drive informed decisions that will improve study outcomes," said Krystyna Kowalczyk, President and CEO of Oncobay Clinical. "By partnering with AiCure and leveraging their unique AI-powered insights, our sponsors will gain a deeper understanding of patient behavior through high-quality data capture and develop comprehensive views of the impact of study drug administration and compliance on other data points. We're excited to further our overall mission of collaborating with innovative, forward-thinking companies to make a difference for our customers and their patients."

For more information: www.aicure.com


Related Content

News | Enterprise Imaging

June 20, 2024 — Agfa announces its participation in the upcoming Society for Imaging Informatics in Medicine (SIIM) 2024 ...

Time June 20, 2024
arrow
News | SIIM

June 20, 2024 — The Society for Imaging Informatics in Medicine (SIIM) is gearing up for its SIIM24 Annual Meeting and ...

Time June 20, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Cybersecurity

June 19, 2024 —Karamba Security, a world leader in end-to-end product security, today announced the signing of a ...

Time June 19, 2024
arrow
News | Artificial Intelligence

June 18, 2024 — The advancement of Artificial Intelligence (AI) in healthcare to support diagnostic decision making ...

Time June 18, 2024
arrow
News | Artificial Intelligence

June 17, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time June 17, 2024
arrow
News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
News | PACS

June 13, 2024 — Cloud-PACS radiology solutions provider SynthesisHealth, Inc. has signed three new contracts with ...

Time June 13, 2024
arrow
News | Digital Radiography (DR)

June 12, 2024 — Carestream launched its Image Suite MR 10 Software to help deliver a boost to productivity and ...

Time June 12, 2024
arrow
Subscribe Now